Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Learn MoreShervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Learn MoreThe Conference Call on Q3 2026 takes place on November 3, 2026
Learn MoreBringing Clarity to Complexity in the Intensive Care Unit: TherapyWise
Learn MoreExplore our new careers site and discover meaningful opportunities to help lead the future of kidney care.
Learn MoreHighVolumeHDF Therapy: Transforming the Standard of Kidney Care
Learn MoreFresenius Medical Care publishes its key financial figures for the third quarter of 2026 on November 3, 2026
Learn More